Carl Hull bought $987K of Maravai Lifesciences (MRVI)

Executed Nov 11 2024, disclosed Nov 12 2024, 1 day later.

Value, as filed

$987K

175,000 sh × $5.64

Executed

Nov 11 2024

the trade date, as filed

Disclosed

Nov 12 2024

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

+1.2%

+10.8% from execution

Over the 21 trading sessions from the disclosed entry session (Nov 12 2024), the stock returned +1.2% (delay-adjusted); from the execution session (Nov 11 2024), +10.8%. Derived: entry at the session's open, exit at the close 20 sessions later.

The filer

CH Carl Hull See Remarks profile →

Carl Hull (See Remarks) filed 1 Form 4 report in the past 24 months (1 purchase, 0 sales), most often in MRVI. Across 1 priced purchase filing, the average 21-session return was +10.8% from execution and +1.2% from disclosure (delay-adjusted; derived). The largest single filing was $987K of MRVI (175,000 sh × $5.64, as filed), executed Nov 11 2024.

The name

MRVI MRVI MRVI · 7 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→